PubMed · 2000 · 42 citations · 12 references
MedicineCell BiologyHematologyCell TherapyRegenerative MedicineStem Cell TransplantationAutologous Stem Cell TransplantationCell EngraftmentEngraftment MonitoringHematopoietic RecoveryHematopoietic Stem Cell TransplantationStem Cell MobilizationAutologous EngraftmentAutologous Stem Cell TherapyMobilization Regimens
INTRODUCTION: This study analyses the factors affecting mobilisation and engraftment in autologous peripheral blood progenitor cell transplantation according to the number of CD34(+) re-infused. MATERIALS AND METHODS: A total of 190 patients underwent mobilisation with G-CSF alone (n=113) or in combination with chemotherapy (n=77). A total of 116 patients (61%) were autografted with <2 x 10(6) CD34(+) cells/kg and 74 patients were transplanted with >2 x 10(6) CD34(+) cells/kg. Rates of granulocyte and platelet recovery were estimated using the product-limit method of Kaplan-Meier and compared using a log-rank test. The Cox regression model was used for the multivariate analysis of factors influencing engraftment. Differences between cohorts were evaluated by one-way ANOVA or Mann-Whitney tests, and multivariate analysis was performed using a stepwise lineal regression. RESULTS: Neutrophil and platelet engraftment was significantly longer with <2 x 10(6)/CD34(+)/kg (12 vs 10 days, P=0.014 and 16 vs 13 days, P=0.0001 respectively). Platelet recovery was affected by exposure to alkylating agents (P=0.04), refractory disease (P=0.02) and AML (P=0.0001), but only the last two variables remained significant in Cox regression (P<0.01). Granulocyte engraftment was longer in CML (univariate, P=0.04) and in refractory disease (multivariate, P=0.02). In patients re-infused with >2 x 10(6)/CD34(+)/kg, the Cox model did not identify prognostic factors for haematopoietic recovery. CONCLUSION: Although mobilisation schedules and disease status influenced not only the yield of progenitor cells, but also the engraftment kinetics, the number of CD34(+) re-infused was the main predictor of haematopoietic recovery. While engraftment succeeded in most of the cases, the re-infusion of >2 x 10(6)/CD34(+)/kg resulted in significantly shorter recovery times.
12
The Biology and Clinical Uses of Blood Stem Cells
L. Bik To, DN Haylock, PJ Simmons et al. · Blood · 1997 · 707 citations · Full text
C H Weaver, B Hazelton, Robert Birch et al. · Blood · 1995 · 621 citations · Full text
Medicine, Cell Biology, Hematology +17
Luen Bik To, Marion M. Roberts, David N. Haylock et al. · PubMed · 1992 · 414 citations
Medicine, Hematology, Cell Therapy +10